Post-authorisation Study to Evaluate the Effectiveness of the Risk Minimisation Activities in the Treatment of SPAF
Post-authorisation Study to Evaluate the Effectiveness of the Risk Minimisation Activities in the Treatment of SPAF
The key focus of this survey will be to collect data on physicians awareness of the content of the Pradaxa® Prescriber Guide and the extent to which risk awareness is communicated to patients. The data collected with atrial fibrillation patients will show if and how well this information is received and understood.
Purpose:
Inclusion criteria:
Exclusion criteria:
As defined in Summary of Product Characteristics for patients treated with Pradaxa®
?eská Lípa, Czechia
?eské Bud?jovice, Czechia
?eský Krumlov, Czechia
B?eclav, Czechia
Benesov U Prahy, Czechia
Haví?ov, Czechia
Havlí?k?v Brod, Czechia
Ho?ovice, Czechia
Ivan?ice, Czechia
Krom??íz, Czechia
Plze?, Czechia
Valasské Mezi?í?í, Czechia
Ambleuteuse, France
Buissière Galant, France
Charbrignac, France
Saint Saud Lacousserie, France
Lalinok, Slovakia
Valasska Bela, Slovakia
Baleares, Spain
Galicia, Spain
Essex, United Kingdom
Surrey, United Kingdom